The Swiss pharmaceuticals company reported fourth-quarter pretax profit of $1.98 billion compared with $936 million during the same period a year ago. "Novartis 4Q Profit Rises, Buoyed by Sales of New Drugs," at 0635 GMT, misstated the period in the second paragraph. The pretax profit and sales figures were for the fourth quarter of 2017, not the third quarter.

(END) Dow Jones Newswires

January 24, 2018 02:15 ET (07:15 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.
Novartis (NYSE:NVS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Novartis Charts.
Novartis (NYSE:NVS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Novartis Charts.